Alerts
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0222 Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Proposed Rituximab Biosimilar (GP2013) vs. EU-Approved Rituximab (RTX) in Patients with Rheumatoid Arthritis: Results from A Randomized Controlled Trial (GP13-201) over 52 Weeks